MetaCap

QTREX Quantum Ltd. (QTEX)

NASDAQ: QTEXHealth CareMedical/Dental InstrumentsUSD

1.00-0.12 (-10.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

QTEX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$70.63M
EPS (TTM)
-$0.35
52-week range
0.283 – 3.85
Day range
0.9768 – 1.10
Volume / Avg
2.89M / 9.21M
Beta
—

52-week range

$0.283$3.85

QTEX stock today

Shares of QTREX Quantum (QTEX) finished lower on Nov 20 at $1.00, a drop of 10.71% or $0.12 per share, versus the S&P 500's 3.70% decline. Trading was light, with 2.89M shares changing hands, about 31% of the average daily volume. At this level, QTEX sits in the middle of its 52-week range of $0.283 to $3.85: 74.0% below the high, set on Jun 1, 2026 and 253.4% above the low.

QTEX is up 11.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 9.3%. QTREX Quantum has posted a net loss over the last twelve months (EPS of -$0.35), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About QTREX Quantum

Company profile

QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements.

Industry
Medical/Dental Instruments
CEO
Mr. Dagi Shahar Ben-Noon
Headquarters
Ra'anana
Employees
34
IPO year
2021
Website
q-trex.com

Financial highlights

Full financials

In fiscal 2025, QTREX Quantum generated $289,000 in revenue, up 0.0% from fiscal 2024. QTREX Quantum reported a net loss of $13.2 million, compared with a loss of $11.1 million a year earlier. Gross margin was 0.7% and operating margin -4713.8%.

QTREX Quantum annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$289.00K$0$0——
Growth—————
Net income$-13.22M$-11.05M$-11.29M$-14.98M$-17.19M
EPS (diluted)$-0.45$-0.60$-0.93$-1.39$-3.24

Analyst forecast

Forecast

Consensus

none

Avg. price target

$5.00+400.00%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

QTEX news

All QTEX news

QTREX Quantum peers

Health Care sector
QTEX peer companies
CompanyPrice% ChgMarket capCompare
LUCDLucid Diagnostics Inc.0.3727-3.52%$72.57Mvs QTEX
SKINSkinHealth Systems Inc. Class A11.77-3.13%$76.68Mvs QTEX
NYXHNyxoah SA0.805-7.01%$81.98Mvs QTEX
LNSRLENSAR Inc.4.46-3.88%$54.83Mvs QTEX
MBOTMicrobot Medical Inc.0.68-8.52%$45.67Mvs QTEX
DXRDaxor Corporation7.45-7.33%$43.49Mvs QTEX
APYXApyx Medical Corporation2.40+0.42%$101.10Mvs QTEX
SRTSSensus Healthcare Inc.2.26-4.24%$37.20Mvs QTEX

Indexes, lists and sector

QTREX Quantum stock FAQ

What is QTREX Quantum's stock price today?

QTEX last traded at $1.00 as of Nov 20, 4:00 PM EST, down 10.71% on the day. Prices are delayed at least 15 minutes.

Who is QTREX Quantum's CEO?

Mr. Dagi Shahar Ben-Noon is the chief executive officer of QTREX Quantum Ltd., which has about 34 employees.

What is the QTEX 52-week high?

The 52-week high for QTEX is $3.85 and the 52-week low is $0.283. The stock is currently 74.0% below its high.

Compare QTEX